|
Market Closed -
Bombay S.E.
06:02:25 2026-09-25 am EDT
|
5-day change | 1st Jan Change | ||
| 138.45 INR | -1.56% |
|
+2.33% | +92.59% |
| Sep. 17 | ZIM Laboratories Limited Incorporates Wholly Owned Subsidiary In Chile | CI |
| Aug. 07 | ZIM Laboratories Limited, Q1 2027 Earnings Call, Aug 07, 2026 |
| Market Cap | 7.41B 77.37M 67.93M 64.09M 58.44M 109M 110M 767M 297M 3.78B 290M 284M 12.17B | P/E 2025 |
32.1x | P/E 2026 | 50.3x |
|---|---|---|---|---|---|
| Enterprise Value | 8.28B 86.38M 75.84M 71.55M 65.24M 122M 123M 856M 331M 4.23B 324M 317M 13.59B | EV / Sales 2025 |
1.34x | EV / Sales 2026 | 1.09x |
| Free-Float |
28.77% | Yield 2025 * |
-
| Yield 2026 | - |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| ZIMLAB | Delayed | |
NSE India S.E.
| ZIMLAB | End-of-day quote |
Last Transcript: ZIM Laboratories Limited
| 1 day | -1.56% | ||
| 1 week | +2.33% | ||
| Current month | +11.97% | ||
| 1 month | +11.07% | ||
| 3 months | +11.79% | ||
| 6 months | +117.62% | ||
| Current year | +92.59% |
| 1 week | 130.35 |  | 143.2 |
| 1 month | 112 | | 144.85 |
| Current year | 59.72 | | 144.85 |
| 1 year | 59.72 | | 144.85 |
| 3 years | 59.72 | | 144.85 |
| 5 years | 36.37 | | 151.75 |
| 10 years | 14 | | 151.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CEO | Chief Executive Officer | - | 2001-12-31 |
| Director of Finance/CFO | - | 2019-03-31 | |
| Director of Finance/CFO | - | 1990-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CHM | Chairman | - | 1989-12-31 |
| Director/Board Member | - | 1990-12-31 | |
Prakash Sapkal
BRD | Director/Board Member | - | 2012-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.56% | +2.33% | +89.04% | +11.20% | 77.35M | |
| +0.12% | +0.81% | +13.81% | +64.78% | 46.37B | |
| +1.09% | +0.36% | +39.50% | +107.67% | 37.26B | |
| +2.00% | +3.78% | +18.12% | +99.54% | 12.53B | |
| +0.05% | +0.37% | -7.29% | +18.68% | 11.8B | |
| 0.00% | 0.00% | +18.72% | +139.63% | 8.97B | |
| -1.34% | -2.73% | +27.67% | +37.52% | 7.09B | |
| -2.07% | -2.75% | +17.20% | +202.97% | 7.01B | |
| +1.43% | +2.22% | +43.10% | -14.21% | 7.29B | |
| -2.45% | -0.59% | -51.49% | +4.53% | 4.99B | |
| Average | -0.27% | +0.38% | +20.84% | +67.23% | 14.34B | |
| Weighted average by Cap. | +0.32% | +0.54% | +19.54% | +79.12% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 3.79B 39.57M 34.74M 32.77M 29.88M 55.97M 56.34M 392M 152M 1.94B 149M 145M 6.22B | 3.74B 39.07M 34.31M 32.36M 29.51M 55.27M 55.64M 387M 150M 1.91B 147M 144M 6.15B |
| Net income | 122M 1.27M 1.11M 1.05M 959K 1.8M 1.81M 12.59M 4.87M 62.1M 4.77M 4.66M 200M | 58.38M 609K 535K 505K 460K 862K 868K 6.04M 2.34M 29.8M 2.29M 2.24M 95.85M |
| Net Debt | 1.16B 12.08M 10.61M 10.01M 9.12M 17.09M 17.2M 120M 46.34M 591M 45.36M 44.37M 1.9B | 863M 9.01M 7.91M 7.46M 6.8M 12.74M 12.83M 89.3M 34.55M 441M 33.82M 33.08M 1.42B |
Employees
632
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-25 | ₹138.45 | -1.56% | 10,677 |
| 26-09-24 | ₹140.65 | +4.53% | 12,704 |
| 26-09-23 | ₹134.55 | +0.64% | 7,657 |
| 26-09-22 | ₹133.70 | -0.19% | 4,678 |
| 26-09-21 | ₹133.95 | -1.00% | 5,345 |
- Stock Market
- Stocks
- ZIMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
